Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trialKim A. Reiss, Robert H. Vonderheide, Thomas B. Karasic et al.|The Lancet Oncology|2022Cited by 137